A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using GATTEX

Description

The main aim of this study is to document the level of knowledge and assess attitudes and behaviors of both participants and physicians regarding the risks and safe use of GATTEX. The survey will be done via internet, telephone, or paper and both physicians and participants will be able to choose the method that is preferred. No study medicines will be provided to participants in this study.

Conditions

Short Bowel Syndrome (SBS)

Talk to us

Study Overview

On this page

Study Details

Study overview

The main aim of this study is to document the level of knowledge and assess attitudes and behaviors of both participants and physicians regarding the risks and safe use of GATTEX. The survey will be done via internet, telephone, or paper and both physicians and participants will be able to choose the method that is preferred. No study medicines will be provided to participants in this study.

Quantitative Testing of Patient and Prescriber Knowledge, Attitudes, and Behavior About GATTEX (Teduglutide) for Injection Safety and Use Information

A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using GATTEX

Condition
Short Bowel Syndrome (SBS)
Intervention / Treatment

-

Contacts and Locations

Lexington

Shire-NPS Pharmaceuticals, INC., Lexington, Massachusetts, United States, 02421

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Respondents who do not agree to participate in the survey.
  • * Respondents who are currently working for and/or whose immediate family members who are currently working for Takeda Pharmaceuticals U.S.A., Inc., NPS Pharmaceuticals, Inc., Shire, UBC, or the Food and Drug Administration (FDA) are not eligible to participate in the survey.
  • * Respondents who reported having a conflict of interest.
  • * HCPs who have opted out of receiving communications about the GATTEX HCP KAB Survey for the current wave

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Takeda,

Study Director, STUDY_DIRECTOR, Takeda

Study Record Dates

2026-12-31